$MBVX MABVAX THERAPEUTICS HOLDINGS, INC. Insider Trading Week 15/2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in MABVAX THERAPEUTICS HOLDINGS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in MABVAX THERAPEUTICS HOLDINGS, INC. in week 15/2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 14 2017 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Sell | S | 2.00 | 1,369 | 2,738 | 21,226 | 22.6 K to 21.2 K (-6.06 %) |
| Apr 14 2017 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Sell | S | 2.00 | 3,885 | 7,770 | 29,206 | 33.1 K to 29.2 K (-11.74 %) |
| Apr 14 2017 | MBVX | MABVAX THERAPEUTIC ... | HANSEN JOHN DAVID | PRESIDENT AND CEO | Sell | S | 2.00 | 10,216 | 20,433 | 61,473 | 71.7 K to 61.5 K (-14.25 %) |
| Apr 11 2017 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Sell | S | 2.00 | 200 | 400 | 22,595 | 22.8 K to 22.6 K (-0.88 %) |
| Apr 11 2017 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Sell | S | 2.00 | 400 | 800 | 22,795 | 23.2 K to 22.8 K (-1.72 %) |
| Apr 11 2017 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Sell | S | 2.01 | 450 | 902 | 23,195 | 23.6 K to 23.2 K (-1.90 %) |
| Apr 11 2017 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Sell | S | 2.00 | 200 | 400 | 33,091 | 33.3 K to 33.1 K (-0.60 %) |
| Apr 11 2017 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Sell | S | 2.00 | 400 | 800 | 33,291 | 33.7 K to 33.3 K (-1.19 %) |
| Apr 11 2017 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Sell | S | 2.01 | 450 | 902 | 33,691 | 34.1 K to 33.7 K (-1.32 %) |
| Apr 11 2017 | MBVX | MABVAX THERAPEUTIC ... | HANSEN JOHN DAVID | PRESIDENT AND CEO | Sell | S | 2.00 | 250 | 500 | 71,689 | 71.9 K to 71.7 K (-0.35 %) |
| Apr 11 2017 | MBVX | MABVAX THERAPEUTIC ... | HANSEN JOHN DAVID | PRESIDENT AND CEO | Sell | S | 2.00 | 560 | 1,120 | 71,939 | 72.5 K to 71.9 K (-0.77 %) |
| Apr 11 2017 | MBVX | MABVAX THERAPEUTIC ... | HANSEN JOHN DAVID | PRESIDENT AND CEO | Sell | S | 2.01 | 666 | 1,335 | 72,499 | 73.2 K to 72.5 K (-0.91 %) |